HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

SIMPLE SUMMARY: HER2 testing in endometrial cancer (EC) has gained renewed interest as a therapeutic target. However, HER2 status has not been investigated in the context of the molecular EC classification. Here, we aimed to determine the clinicopathological features and prognostic significance of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermij, Lisa, Horeweg, Nanda, Leon-Castillo, Alicia, Rutten, Tessa A., Mileshkin, Linda R., Mackay, Helen J., Leary, Alexandra, Powell, Melanie E., Singh, Naveena, Crosbie, Emma J., Smit, Vincent T.H.B.M., Creutzberg, Carien L., Bosse, Tjalling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795222/
https://www.ncbi.nlm.nih.gov/pubmed/33375706
http://dx.doi.org/10.3390/cancers13010044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795222/
https://www.ncbi.nlm.nih.gov/pubmed/33375706
http://dx.doi.org/10.3390/cancers13010044

Ejemplares similares